184 related articles for article (PubMed ID: 9927492)
21. Interleukin-6 induces G1 arrest through induction of p27(Kip1), a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells.
Mori S; Murakami-Mori K; Bonavida B
Biochem Biophys Res Commun; 1999 Apr; 257(2):609-14. PubMed ID: 10198259
[TBL] [Abstract][Full Text] [Related]
22. sst2 somatostatin receptor mediates cell cycle arrest and induction of p27(Kip1). Evidence for the role of SHP-1.
Pagès P; Benali N; Saint-Laurent N; Estève JP; Schally AV; Tkaczuk J; Vaysse N; Susini C; Buscail L
J Biol Chem; 1999 May; 274(21):15186-93. PubMed ID: 10329727
[TBL] [Abstract][Full Text] [Related]
23. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
Farley J; Gray K; Nycum L; Prentice M; Birrer MJ; Jakowlew SB
Gynecol Oncol; 2000 Aug; 78(2):113-22. PubMed ID: 10926789
[TBL] [Abstract][Full Text] [Related]
24. Expression of p27kip1 in prostatic adenocarcinoma.
Cheville JC; Lloyd RV; Sebo TJ; Cheng L; Erickson L; Bostwick DG; Lohse CM; Wollan P
Mod Pathol; 1998 Apr; 11(4):324-8. PubMed ID: 9578081
[TBL] [Abstract][Full Text] [Related]
25. Modulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by cell cycle inhibitors.
Wartenberg M; Fischer K; Hescheler J; Sauer H
Biochim Biophys Acta; 2002 Feb; 1589(1):49-62. PubMed ID: 11909640
[TBL] [Abstract][Full Text] [Related]
26. The expression of p18INK4 and p27kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation.
Schrantz N; Beney GE; Auffredou MT; Bourgeade MF; Leca G; Vazquez A
J Immunol; 2000 Oct; 165(8):4346-52. PubMed ID: 11035070
[TBL] [Abstract][Full Text] [Related]
27. Requirement for p27(KIP1) in retinoblastoma protein-mediated senescence.
Alexander K; Hinds PW
Mol Cell Biol; 2001 Jun; 21(11):3616-31. PubMed ID: 11340156
[TBL] [Abstract][Full Text] [Related]
28. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival.
Del Pizzo JJ; Borkowski A; Jacobs SC; Kyprianou N
Am J Pathol; 1999 Oct; 155(4):1129-36. PubMed ID: 10514396
[TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
[TBL] [Abstract][Full Text] [Related]
30. E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1).
St Croix B; Sheehan C; Rak JW; Flørenes VA; Slingerland JM; Kerbel RS
J Cell Biol; 1998 Jul; 142(2):557-71. PubMed ID: 9679152
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.
Vis AN; Noordzij MA; Fitoz K; Wildhagen MF; Schröder FH; van der Kwast TH
J Urol; 2000 Dec; 164(6):2156-61. PubMed ID: 11061947
[TBL] [Abstract][Full Text] [Related]
32. Accumulation of a form of p27(Kip1) not associated with Cdk-cyclin complexes in transforming growth factor-beta-arrested Mv1Lu cells.
Taipale M; Tiihonen E; Heiskanen A; Laiho M
Exp Cell Res; 2000 Aug; 259(1):107-16. PubMed ID: 10942583
[TBL] [Abstract][Full Text] [Related]
33. Multiple functions of p27(Kip1) and its alterations in tumor cells: a review.
Sgambato A; Cittadini A; Faraglia B; Weinstein IB
J Cell Physiol; 2000 Apr; 183(1):18-27. PubMed ID: 10699962
[TBL] [Abstract][Full Text] [Related]
34. Protein kinase Cdelta inhibition of S-phase transition in capillary endothelial cells involves the cyclin-dependent kinase inhibitor p27(Kip1).
Ashton AW; Watanabe G; Albanese C; Harrington EO; Ware JA; Pestell RG
J Biol Chem; 1999 Jul; 274(30):20805-11. PubMed ID: 10409620
[TBL] [Abstract][Full Text] [Related]
35. Expression of cell-cycle-regulated proteins pRb2/p130, p107, p27(kip1), p53, mdm-2, and Ki-67 (MIB-1) in prostatic gland adenocarcinoma.
Claudio PP; Zamparelli A; Garcia FU; Claudio L; Ammirati G; Farina A; Bovicelli A; Russo G; Giordano GG; McGinnis DE; Giordano A; Cardi G
Clin Cancer Res; 2002 Jun; 8(6):1808-15. PubMed ID: 12060621
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
[TBL] [Abstract][Full Text] [Related]
37. Reduced expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in human colon cancer.
Sgambato A; Ratto C; Faraglia B; Merico M; Ardito R; Schinzari G; Romano G; Cittadini AR
Mol Carcinog; 1999 Nov; 26(3):172-9. PubMed ID: 10559792
[TBL] [Abstract][Full Text] [Related]
38. Mimosine arrests cells in G1 by enhancing the levels of p27(Kip1).
Wang G; Miskimins R; Miskimins WK
Exp Cell Res; 2000 Jan; 254(1):64-71. PubMed ID: 10623466
[TBL] [Abstract][Full Text] [Related]
39. Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53.
Lee CC; Ichihara T; Yamamoto S; Wanibuchi H; Sugimura K; Wada S; Kishimoto T; Fukushima S
Carcinogenesis; 1999 Sep; 20(9):1697-708. PubMed ID: 10469613
[TBL] [Abstract][Full Text] [Related]
40. Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinoma.
Franke KH; Miklosi M; Goebell P; Clasen S; Steinhoff C; Anastasiadis AG; Gerharz C; Schulz WA
Urology; 2000 Oct; 56(4):689-95. PubMed ID: 11018640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
